These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 12464713)

  • 1. Frontotemporal dementia: paroxetine as a possible treatment of behavior symptoms. A randomized, controlled, open 14-month study.
    Moretti R; Torre P; Antonello RM; Cazzato G; Bava A
    Eur Neurol; 2003; 49(1):13-9. PubMed ID: 12464713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: a double-blind randomized controlled trial.
    Deakin JB; Rahman S; Nestor PJ; Hodges JR; Sahakian BJ
    Psychopharmacology (Berl); 2004 Apr; 172(4):400-8. PubMed ID: 14666399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frontotemporal dementia: treatment response to serotonin selective reuptake inhibitors.
    Swartz JR; Miller BL; Lesser IM; Darby AL
    J Clin Psychiatry; 1997 May; 58(5):212-6. PubMed ID: 9184615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral symptoms in dementia: community-based research.
    Auer SR; Monteiro IM; Reisberg B
    Int Psychogeriatr; 1996; 8 Suppl 3():363-6; discussion 381-2. PubMed ID: 9154589
    [No Abstract]   [Full Text] [Related]  

  • 5. Selective serotonin re-uptake inhibitors for the treatment of perseverative and maladaptive behaviours of people with intellectual disability.
    Branford D; Bhaumik S; Naik B
    J Intellect Disabil Res; 1998 Aug; 42 ( Pt 4)():301-6. PubMed ID: 9786445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frontotemporal dementia: recommendations for therapeutic studies, designs, and approaches.
    Freedman M
    Can J Neurol Sci; 2007 Mar; 34 Suppl 1():S118-24. PubMed ID: 17469694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment approaches to symptoms associated with frontotemporal degeneration.
    Chow TW
    Curr Psychiatry Rep; 2005 Oct; 7(5):376-80. PubMed ID: 16216158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paroxetine treatment of sexual disinhibition in dementia.
    Stewart JT; Shin KJ
    Am J Psychiatry; 1997 Oct; 154(10):1474. PubMed ID: 9326839
    [No Abstract]   [Full Text] [Related]  

  • 9. Frontotemporal dementia: a randomised, controlled trial with trazodone.
    Lebert F; Stekke W; Hasenbroekx C; Pasquier F
    Dement Geriatr Cogn Disord; 2004; 17(4):355-9. PubMed ID: 15178953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Alzheimer's disease.
    Hausner RS
    N Engl J Med; 2004 Jan; 350(1):80-2; author reply 80-2. PubMed ID: 14708131
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of frontotemporal dementia].
    Lebert F
    Psychol Neuropsychiatr Vieil; 2004 Mar; 2(1):35-42. PubMed ID: 15683967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of Dementia Among Elderly Nursing Home Patients Using Paroxetine and Other Selective Serotonin Reuptake Inhibitors.
    Bali V; Chatterjee S; Carnahan RM; Chen H; Johnson ML; Aparasu RR
    Psychiatr Serv; 2015 Dec; 66(12):1333-40. PubMed ID: 26234334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paroxetine in social anxiety disorder: a randomized placebo-controlled study.
    Allgulander C
    Acta Psychiatr Scand; 1999 Sep; 100(3):193-8. PubMed ID: 10493085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Social behaviour vs. psychiatric features of frontotemporal dementia - Clinical report of two cases.
    Liscić RM; Kogoj A
    Psychiatr Danub; 2010 Jun; 22(2):179-82. PubMed ID: 20562743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.
    Rosenbaum JF; Fava M; Hoog SL; Ascroft RC; Krebs WB
    Biol Psychiatry; 1998 Jul; 44(2):77-87. PubMed ID: 9646889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tiagabine for the treatment of generalized anxiety disorder: a randomized, open-label, clinical trial with paroxetine as a positive control.
    Rosenthal M
    J Clin Psychiatry; 2003 Oct; 64(10):1245-9. PubMed ID: 14658975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral disturbances of dementia and caregiver issues.
    Zarit SH
    Int Psychogeriatr; 1996; 8 Suppl 3():263-8; discussion 269-72. PubMed ID: 9154574
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypersensitivity to paroxetine.
    Mera MT; Pérez BV; Fernández RO; Iglesias JF
    Allergol Immunopathol (Madr); 2006; 34(3):125-6. PubMed ID: 16858890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stereotyped behaviors and compulsive complaints of pain improved by fluvoxamine in two cases of frontotemporal dementia].
    Ishikawa H; Shimomura T; Shimizu T
    Seishin Shinkeigaku Zasshi; 2006; 108(10):1029-35. PubMed ID: 17240851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mild behavioral impairment: a prodromal stage of frontotemporal lobar degeneration.
    Schölzel-Dorenbos CJ
    J Am Geriatr Soc; 2006 Jan; 54(1):180-1. PubMed ID: 16420228
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.